Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Outpatient, Safety and Efficacy Study of TAK-375 in Adults With Chronic Insomnia

NCT00671567 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00671567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00671567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Outpatient, Safety and Efficacy Study of TAK-375 in Adults With Chronic Insomnia
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2002
Completion date
September 30, 2003
Enrollment
848 (actual)
Sites
70

Conditions

As the registry lists them; a condition with its own page is linked.

chronic insomnia